logo

IH

iHuman·NYSE
--
--(--)
--
--(--)
9.33 / 10
Outperform

Assessment shows superior fundamentals at 9.3/10. Constructive elements: Asset-MV and Cash-UP, while concerns exist in Equity ratio (Total liabilities / Shareholders’ equity attributable to parent company) (%) and Current assets / Total assets (%). Investment case: very promising.

Fundamental(9.33)SentimentTechnical

Analysis Checks(6/10)

Revenue-MV
Value0.05
Score3/3
Weight69.59%
1M Return8.19%
Gross profit margin (%)
Value68.17
Score2/3
Weight9.83%
1M Return1.31%
Equity ratio (Total liabilities / Shareholders’ equity attributable to parent company) (%)
Value0.39
Score0/3
Weight-15.17%
1M Return-2.33%
Profit-MV
Value2.99
Score2/3
Weight31.26%
1M Return3.45%
Non-current assets / Total assets (%)
Value5.08
Score0/3
Weight-23.24%
1M Return-3.61%
Cash-UP
Value-0.06
Score2/3
Weight-16.89%
1M Return-3.63%
Long-term debt to working capital ratio (%)
Value0.01
Score0/3
Weight-19.41%
1M Return-3.06%
Cost of sales ratio (%)
Value31.83
Score2/3
Weight9.83%
1M Return1.32%
Asset-MV
Value-0.50
Score2/3
Weight75.18%
1M Return8.74%
Current assets / Total assets (%)
Value94.92
Score0/3
Weight-20.98%
1M Return-3.16%
Is IH undervalued or overvalued?
  • IH scores 9.33/10 on fundamentals and holds a Discounted valuation at present. Backed by its 8.23% ROE, 12.62% net margin, 6.39 P/E ratio, 0.67 P/B ratio, and -65.43% earnings growth, these metrics solidify its Outperform investment rating.